Japanese spotted fever and adjunctive fluoroquinolones: a critical appraisal of hard outcome evidence
FUKUSHIMA JOURNAL OF MEDICAL SCIENCE · 2026
DOI: 10.5387/fms.26-00024 ↗Kurz gefasst
Fachartikel in der Zeitschrift FUKUSHIMA JOURNAL OF MEDICAL SCIENCE, 2026. Verfasst von Eiichiro Sando. Beteiligte Einrichtung: Department of Infection Control, Fukushima Medical University. Die Arbeit nennt 44 Literaturangaben.
Abstract (Originalsprache)
Japanese spotted fever (JSF) is a tick-borne disease caused by Rickettsia japonica, for which tetracycline-based therapy has long been the standard treatment. Since the early 2000s, adjunctive fluoroquinolone use has become more common in severe cases. However, its impact on hard outcomes has not been established. This review examines the emergence of combination therapy. It appraises the evidence by focusing on study design, escalation timing, and outcome definitions. Two retrospective cohort studies found no mortality benefit with combination therapy. One of these cohort studies also suggested possible harm in a subgroup analysis. A pooled analysis of case reports and case series described shorter time to defervescence with combination therapy, but these data are vulnerable to reporting bias, and defervescence does not demonstrate benefit in hard outcomes. Overall, current evidence is insufficient to support routine adjunctive fluoroquinolone use.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Infection Control, Fukushima Medical University.
Zitieren
APA
Sando, E. (2026). Japanese spotted fever and adjunctive fluoroquinolones: a critical appraisal of hard outcome evidence. FUKUSHIMA JOURNAL OF MEDICAL SCIENCE. https://doi.org/10.5387/fms.26-00024
Vancouver
Sando E. Japanese spotted fever and adjunctive fluoroquinolones: a critical appraisal of hard outcome evidence. FUKUSHIMA JOURNAL OF MEDICAL SCIENCE. 2026. doi:10.5387/fms.26-00024
BibTeX
@article{Sando2026,
author = {Sando, Eiichiro},
title = {Japanese spotted fever and adjunctive fluoroquinolones: a critical appraisal of hard outcome evidence},
journal = {FUKUSHIMA JOURNAL OF MEDICAL SCIENCE},
year = {2026},
doi = {10.5387/fms.26-00024}
}
EUVIMED